Waitan Ludi Policy Terminal

Country-interest evidence · pilot

Trade inferences use UN Comtrade, with China as reporter. Country connections indicate potential trade relevance, not measured harm, firm-level exposure or legal applicability. Inward measures concern exporters to China; competition with Chinese exports in third markets is not assessed.

Inspect implementing jurisdictions and partner evidence · 106 relationships

Argentina: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 69,708,777

Australia: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 347,554,302

Austria: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 787,052,998

Belgium: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 659,952,960

Bulgaria: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 12,367,403

Brazil: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 63,760,818

Barbados: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 13,658,630

Canada: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 553,044,437

Switzerland: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 3,042,352,813

Costa Rica: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 461,676,274

Cuba: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 2,122,770

Cyprus: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 8,443,247

Czech Republic: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 60,215,252

Germany: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 12,851,752,500

Denmark: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 1,264,251,952

Dominican Republic: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 82,283,257

Egypt, Arab Rep.: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 2,620,274

Spain: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 776,449,609

Estonia: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 1,505,449

Finland: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 250,178,343

France: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 3,461,239,269

United Kingdom: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 2,025,461,604

Greece: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 257,722,163

Hong Kong, China: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 432,873,959

Hungary: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 86,628,754

Indonesia: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 16,465,883

India: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 257,072,949

Ireland: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 5,921,976,690

Iceland: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 4,020,768

Israel: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 576,698,065

Italy: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 2,638,877,534

Japan: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 3,780,975,979

Korea, Rep.: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 917,574,845

Lithuania: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 8,810,777

Mexico: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 2,060,166,605

Malaysia: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 197,309,424

Netherlands: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 1,302,334,693

Norway: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 78,449,973

Nepal: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 2,053,440

New Zealand: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 86,494,773

Pakistan: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 14,010,956

Philippines: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 12,303,924

Poland: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 110,951,665

Portugal: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 3,463,178

Romania: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 3,821,290

Russian Federation: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 6,349,932

Serbia: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 1,342,599

Singapore: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 834,401,327

Slovak Republic: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 2,266,941

Slovenia: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 47,497,280

Sweden: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 1,828,277,424

Thailand: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 110,489,760

Tunisia: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 1,273,372

Turkey: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 34,763,897

Chinese Taipei: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 415,438,553

Uruguay: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 14,515,472

United States: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 12,586,150,022

Vietnam: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 341,228,805

South Africa: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63828 · recorded trade USD 20,291,311

Implementing jurisdiction: China · intervention 63828

Argentina: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 69,708,480

Australia: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 233,082,391

Austria: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 488,733,938

Belgium: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 646,464,139

Bulgaria: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 7,911,484

Brazil: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 52,379,532

Canada: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 462,466,710

Cuba: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 2,122,770

Cyprus: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 8,443,247

Germany: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 9,015,813,964

Denmark: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 1,143,710,075

Spain: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 733,740,259

Finland: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 189,209,596

France: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 3,001,738,660

Greece: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 257,613,585

Hungary: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 46,212,205

Indonesia: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 6,355,319

India: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 136,054,329

Ireland: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 5,066,295,867

Israel: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 32,258,454

Italy: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 2,419,795,476

Japan: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 1,620,109,460

Korea, Rep.: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 188,534,708

Lithuania: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 5,715,925

Mexico: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 4,083,993

Norway: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 24,122,221

New Zealand: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 52,820,259

Poland: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 67,483,400

Portugal: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 3,440,439

Singapore: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 504,462,605

Slovenia: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 16,156,342

Sweden: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 1,699,991,895

Thailand: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 11,775,674

Uruguay: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 14,515,472

Vietnam: Trade-based inference; exporters to China; summed product trade > USD 1m; 2021 trade; broad sector headings; computed, not analyst-reviewed · intervention 63829 · recorded trade USD 2,908,143

Implementing jurisdiction: China · intervention 63829

Assessment states

Trade-based partners recorded
Trade-based partners recorded

Measures

Capital grant

Prefectural · origin: Chinese firms or production in China · locality: Local firms · CPC 352; 481 · Keyword screen (unreviewed)

Implemented by China (subnational) · affects 59 partners (inferred from trade data, 2021 trade): Germany, United States, Ireland, Japan, France, Switzerland …

Stated rationale

Innovation & R&D · section heading · unreviewed 支持科技成果转化。

支持创新药物及医疗器械产业化，对取得创新药、改良型新药、仿制药、原料药药品注册证书并首次在本市实现产业化的，在省级奖励基础上，按照类别每个品种分别给予100万元、50万元、30万元、20万元奖励；

Supports production in a place, so favours that place by rule.

Interest subsidy

Prefectural · origin: Chinese firms or production in China · locality: Local firms · CPC 352 · Keyword screen (unreviewed)

Implemented by China (subnational) · affects 45 partners (inferred from trade data, 2021 trade): Germany, United States, Ireland, France, Italy, Switzerland …

实施美国、欧盟等发达国家GMP改造，对符合条件的项目按程序列入省重点技术改造项目，给予企业技改设备投资奖补、技改项目融资贴息等政策支持，由省级财政按项目设备（含技术、软件等）投资额不超过5%的比例给予补助，单个企业最高不超过500万元，省级工业龙头企业不超过1000万元。

Supports production in a place, so favours that place by rule.

Same central policy, other provinces

国家发展改革委工业和信息化部关于推动原料药产业高质量发展实施方案的通知 · 发改产业〔2021〕1523号 · 2021-10-29 · answered in 1 province held · trace it ↗

Province	First document citing it	Dated	Lag
Fujian	this document	2022-09-05	311 d

Held documents only: these are counts of what we have collected, not of what each province issued.

Full text

各县（市、区）人民政府，市直各单位：《三明市加快生物医药产业高质量发展行动计划（2022—2025年）》已经市政府同意，现印发给你们，请认真组织实施。三明市人民政府 2022年9月5日三明市加快生物医药产业高质量发展行动计划（2022—2025年）为加快推动我市生物医药产业优化提升，促进产业高质量发展，根据《福建省加快生物医药产业高质量发展实施方案》《三明市“十四五”工业高质量发展专项规划》等有关精神，结合我市实际，制定本行动计划。一、总体要求坚持以习近平新时代中国特色社会主义思想为指导，全面贯彻落实党的十九大和十九届历次全会精神，完整、准确、全面贯彻新发展理念，面向人民健康，大力发展生物医药产业，进一步强产业、育龙头、建集群、创优势，加快构建布局合理、结构优化、产品优质、特色鲜明、竞争力强的现代生物医药产业体系。 ——坚持创新发展。突出科技赋能，推动互联网、大数据、人工智能和生物医药产业发展深度融合，加强政产学研用深度对接，促进技术、产品和商业模式创新，构建一批产业通用中试平台、产业应用基础平台、注册审批检验平台等生物医药研发创新服务平台，推动一批创新成果转化与产业化。 ——坚持协调发展。坚持“全市一盘棋”，强化市县联动，共同构建差异化错位发展产业格局，加快推动生物医药产业链上下游协作配套，促进产业集聚、转型升级。其中：三元重点发展化学药、中药、诊断试剂产业；沙县重点发展真菌发酵药物、高端医疗器械产业；永安重点发展生物食品、生物化工；明溪重点发展抗肿瘤药物、医药中间体和原料药产业；尤溪重点发展食品及日化产品香精香料产业；大田、清流、宁化、将乐、泰宁、建宁等突出发展中药材种植及相关提取产业。 ——坚持绿色发展。依托三明生态资源禀赋，推广中药材绿色标准化种植，加强全过程可追溯中药材种植基地建设，推动中药材相关产品的研发、生产、流通、销售全产业链融合发展。大力实施绿色改造、清洁生产，推动绿色生物技术在生物医药领域的示范应用，建立生态安全、绿色低碳、循环发展的生物医药产业绿色发展体系。 ——坚持开放发展。更好地融入国内大循环格局，深化京闽（明）、沪明、闽西南等对口合作，加强与中关村国家自主创新示范区、张江药谷、厦门生物医药港等国内生物医药产业重点集聚区以及中国外商投资企业协会生物科技创新委员会的对接，深化信息共享、产业配套、基地建设等领域合作，促进在项目研发、成果转化、产业基地、招商引资等方面尽快取得一批实实在在的成果。 ——坚持共享发展。用好三明医改“金字招牌”，推动改革优势转化为产业发展优势，促进医疗卫生事业和生物医药产业融合发展，完善现有的公共卫生应急医疗物资保障体系，提高人民群众获得感、幸福感、安全感。以打造“福九味”“明八味”药材知名品牌为抓手，加快中药材种植、中药材加工、中医药文化融合发展，带动群众增收致富，助推乡村产业振兴。二、发展目标到2025年，全市生物医药产业链支撑体系更加健全，生物医药产业集群具备一定规模，生产管理规范化程度进一步提高，行业数字化应用水平明显提升，建成一批技术研发和公共服务平台，全市规模以上生物医药企业产值突破255亿元、年均增幅保持10%左右，培育形成年销售额超1亿元的生物医药企业10家以上，新增国家二类以上医疗器械5个以上、国药准字号3个以上，年销售额亿元以上产品2个以上。三、重点任务用好用足三明工业基础、天然药用植物资源，打造从中草药到中成药、从中间体到原料药到制剂的全产业链，延伸医疗器械+大数据+大健康产业，加快构建生物医药“321”产业发展体系，即重点发展“3个特色产业”、打造“2个产业基地”、培育“1个大健康产业”。（一）特色医药产业 1.特色中药产业。依托我市丰富的林下资源，按照“龙头企业+科研院所+合作社+基地”模式，推动建设一批特色道地药材标准化及重点中成药品种所需中药材原料种植(养殖）基地。深化与中国中医科学院、中国林科院林化所等科研机构合作，提升中药材及天然药用植物有效成分提取、分离与纯化技术，推动我市痛血康胶囊、猕猴桃颗粒、冠脉乐片、山楂精降脂片等全国独家中成药品种进行新工艺研发和二次开发，做大做强传统名优中成药品种，延伸以中药材为主要原料的药膳、保健食品、提取物等相关产业链。挖掘我市特色畲族医药，加强保护传承与开发。支持汇天生物开发国医大师名方1.1类中药创新药“玉蝴蝶祛斑膏”等中药品种，争取痛血康胶囊纳入国家基本药物目录。对接引进华润医药等知名药企来明投资布局中成药、中药制剂、中药配送中心、中医药文化展览为一体的特色中医药产业园。责任单位：市林业局、工信局、农业农村局、科技局、卫健委、医保局、市场监管局，各县（市、区）人民政府 2.特色原料药制剂产业。加快生物医药产业和氟新材料融合发展，推动我市特色医药品种从医药中间体→原料药→制剂（片剂）一体化发展，打造六氟异丙醇→七氟烷中间体及原料药→七氟烷制剂的吸入式麻醉剂生产基地，推动地氟烷、七氟烷、异氟烷等原料药及制剂的药号审批落地形成产业化。加快氟新材料产业链拓展延伸，支持海西联合药业、高宝科技、明行健康、海斯福等企业生产七氟烷、氟苯、对氟苯甲酰氯、二氟吡啶等含氟医药中间体。打造红豆杉种植→提取天然紫杉醇、10DAB→多西他赛、卡巴他赛等抗肿瘤原料药→紫杉醇制剂等抗肿瘤药品生产基地，加快推进明溪南方制药抗肿瘤新药系列产品生产项目（三期）项目建设，带动紫杉园等抗肿瘤企业发展壮大，打造成全球紫杉烷类产品重要的供应商。打造蕲蛇养殖→取蕲蛇蛇毒→冻干层析→分离纯化→蕲蛇酶注射液的脑梗塞药品生产基地，加快适应症等临床研究。支持汇天生物来氟米特片按照仿制药一致性评价标准，推动来氟米特原料药→来氟米特片成品药一体化生产，提升产品质量与疗效。积极主动融入沪明对口合作、闽西南协同发展区建设，依托我市资源优势对接合作一批特色原料药产业项目，形成紧密的产业链分工协作关系。责任单位：市工信局、科技局、发改委、商务局、市场监管局、生态环境局，各县（市、区）人民政府 3.特色生物技术产业。聚焦分子生物学、细胞工程等现代生物技术，发展以生物医药为重点的大健康产业，重点推进合成生物学、真菌发酵工程、生物资源综合应用、新型诊断试剂等技术研究和产品开发，加快熙翔制药原料药和高端中间体研发生产、沃兰香料、欧劳福林香精香料等项目建设；推动万科药业维生素D3生产项目、天泰制药天麻蜜环菌原料技改等一批项目建成投产；鼓励博峰生物新型冠状病毒抗原检测试剂进行临床试验，并申报国家三类医疗器械文号，加快实现产业化。责任单位：市工信局、科技局、发改委、市场监管局，各县（市、区）人民政府（二）生物医药产业基地 1.建强三明（明溪）原料药绿色生产基地。深入贯彻国家四部委制定印发的《推动原料药产业绿色发展的指导意见》《关于推动原料药产业高质量发展实施方案的通知》有关精神，以我市与省药监局签订的《共同建设三明（明溪）原料药绿色生产基地合作备忘录》为契机，加快打造福建省重要的原料药绿色生产基地。建立三明原料药绿色生产联席会议制度，发挥市级“联络办”、明溪县“服务工作站”等作用，全力做好协调服务，重点培育壮大海斯福化工、海西联合药业、旻和药业等医药中间体骨干企业，加快推动原料药及医药中间体产业化项目；争取上海医药等国企同三明生物医药企业建立战略合作伙伴关系，共促药品研发，共建原料药绿色生产基地；积极在治疗糖尿病、抗感染、抗病毒、手术用麻醉剂等领域开拓市场。责任单位：市工信局、市场监管局、卫健委，明溪县等相关县（市、区）人民政府 2.打造中关村科技园生物医药产业基地。借鉴中关村全国30多个合作城市和地区的成功经验和模式，依托中关村生物医药产业技术、人才、项目资源，招引一批填平补齐产业链的大项目好项目。用好国家中医药管理局、华润集团等国家机关、央企对口支援我市政策优势，推动华润集团来明布局中成药、中药制剂、中药配送中心、中医药文化展览为一体的特色中医药产业项目，力争至2025年新引进企业15家以上。争取上海张江高新区、紫竹高新区与我市开展产业合作，在上海建立三明中关村科技园离岸孵化器，并促成一批生物医药孵化项目在三明落地。责任单位：市工信局、科技局、发改委、市场监管局、生态工贸区管委会，相关县（市、区）人民政府（三）大健康产业立足大健康产业、中医药市场需求，加快发展中药材提取、中药饮片、保健品、特医食品等中医药健康产品，加快推进明溪沃林大健康系列产品生产项目建设。推动“明八味”产业研究院与医工总院三明分院开展“药食同源”研究，研制系列药膳包、功能性产品，强化宣传营销，促进三明药膳与沙县小吃产业融合发展。依托机科院海西分院和半固态技术研究所技术，开展医工结合研发创新，开发智能家庭健康产品、慢性病监测管理、远程健康管理等健康管理设备。借助沪明、厦明合作契机，重点在智能医学、救援医学、脑科学、医疗仪器等学科方向深化交流合作，加快推进三明“智慧医院”建设。责任单位：市工信局、科技局、发改委、市场监管局、卫健委，各县（市、区）人民政府，三明医学科技职业学院四、政策措施（一）提升产业技术创新能力 1.支持服务平台建设。支持高校、科研院所及企业组建医药科技研发创新平台，加快医工总院三明分院生物医药公共服务平台建设。对新认定为省级及以上企业技术中心、工程研究中心、新型研发机构、重点实验室的企业，积极争取省级相关补助资金支持。支持园区和企业建设生物医药通用中试平台、注册审批检验平台等生物医药产业公共服务平台，建设医药合同研发机构（CRO）、合同生产机构（CMO）、合同研发生产机构（CDMO）等产业应用基础平台。责任单位：市科技局、工信局、发改委、财政局，各县（市、区）人民政府，三明医学科技职业学院 2.支持科技成果转化。支持创新药物及医疗器械产业化，对取得创新药、改良型新药、仿制药、原料药药品注册证书并首次在本市实现产业化的，在省级奖励基础上，按照类别每个品种分别给予100万元、50万元、30万元、20万元奖励；对第二类、第三类医疗器械取得注册证书并首次在本市实现产业化的，在省级奖励基础上，每个品种分别给予20万元、30万元奖励；单个企业每年最高奖励金额不超过100万元。责任单位：市工信局、市场监管局、财政局，各县（市、区）人民政府 3.支持一致性评价。对省内药品上市许可持有人属国内首家通过、前三个通过和通过（含视同通过）仿制药质量和疗效一致性评价的品种，积极争取省级奖励。对通过仿制药质量和疗效一致性评价的医保目录内品种，在医保支付方面予以支持，鼓励医疗机构优先采购和使用。责任单位：市科技局、市场监管局、工信局、医保局、卫健委、财政局，各县（市、区）人民政府（二）提升产业核心竞争力 1.推进数字赋能。推动生物医药企业进行数字化、网络化、智能化转型升级，形成一批智能制造示范标杆企业和典型案例企业，推动南方制药智能化绿色高端定制原料药生产车间、熙翔制药合同研发生产机构（CDMO）建设。为生物医药产业发展顶层设计优化提供数据和决策支撑，以产业链图谱、产业评价指标体系为基础，助力产业决策和资源配置，为全市生物医药企业提供全生命周期、全要素、全价值链服务。责任单位：市工信局、发改委、科技局，各县（市、区）人民政府 2.支持企业转型升级。鼓励生物医药企业加强自动化、信息化、智能化、绿色化改造，运用新技术、新设备、新工艺、新材料，对现有生产设施、工艺条件、生产环境等进行升级，加快构建绿色制造体系,推动绿色技术应用、绿色产品开发、绿色工厂建设、绿色园区创建。实施美国、欧盟等发达国家GMP改造，对符合条件的项目按程序列入省重点技术改造项目，给予企业技改设备投资奖补、技改项目融资贴息等政策支持，由省级财政按项目设备（含技术、软件等）投资额不超过5%的比例给予补助，单个企业最高不超过500万元，省级工业龙头企业不超过1000万元。应急医疗物资项目设备投资补助最高比例由5%提高到10%，单个项目最高1000万元。责任单位：市工信局、财政局，各县（市、区）人民政府 3.支持中医药产品保护与开发。支持我市特色药用植物种质资源收集、保护和利用工作，加快中药材绿色标准化种植，加强优质中药材生产种植基地建设。大力推广林下中药材套种模式，并积极拓展产业链，形成集旅游观光、中药果蔬采摘为一体的现代新农村中药材套种基地。重点开发“明八味”等药食同源产品，打造若干道地药材大宗品种种植基地，形成中药材相关产品研发、生产、流通、销售全产业链发展，对在三明市域内建设道地药材50亩以上规范化全过程可追溯种植基地，产品符合国家或省级标准的，经评审合格给予每个种植基地25万元奖励，每个单位每年支持额度不超过50万元。支持高校、科研院所和企业联合开展特色药用植物良种繁育、良法种植，对获得国家级中药材品牌认证、省级及以上认定的新品种、地方标准，给予高校或科研院所20万元的一次性奖励。支持符合条件的中药生产企业进行中药饮片（含配方颗粒）科研、生产及临床使用，对利用本地中药材资源，取得中药配方颗粒生产试点并建成投产的，一次性奖励50万元。鼓励企业制定道地中药材行业标准和团体标准，积极争取省上奖励。责任单位：市工信局、科技局、农业农村局、林业局、卫健委、市场监管局、财政局，各县（市、区）人民政府 4.加强企业梯度培育。建立企业成长培育库，对新增投产的规上生物医药企业和规下转规上的生物医药企业，在兑现省上奖励的基础上，由市财政给予每家5万元奖励，县级财政相应配套奖励。实施“专精特新”工程，以“高精尖缺”为导向，坚持专业化、精细化、特色化、新颖化发展路径，对照国家和省“专精特新”中小企业认定标准，培育打造一批专注细分领域、专业化水平高、创新能力强的专精特新“小巨人”生物医药企业。责任单位：市工信局、统计局、财政局，各县（市、区）人民政府（三）提升企业市场开拓能力 1.支持产品挂网销售。我市药品和医疗器械在不高于同类产品采购入围价的情况下，依企业申请及医疗机构临床需求，按规定纳入我市药械联合限价采购目录。支持地方特色、重点品种，按有关规定申报国家基本医疗保险药品目录。责任单位：市医保局、卫健委、工信局、市场监管局，各县（市、区）人民政府 2.支持医药企业对接。2024年底前，各县（市、区）工信部门牵头举办（含承办）的各类线上或线上线下相结合的促销活动，按当地财政补助资金的50%给予补助，每场活动最高补助100万元。对参会生物医药企业多、效果明显的“手拉手”供需对接活动，给予一定奖励。责任单位：市工信局、财政局，各县（市、区）人民政府 3.支持开展应用示范。支持生物医药企业申报《福建省工业和信息化重点新产品目录》，对列入目录的创新产品，可依法实行政府首购和订购，加强宣传推广和采购使用。通过首台（套）重大技术装备保险补偿试点工作，支持高端医疗装备推广应用。丰富医疗保障产品，发挥商业健康保险在健康保障领域的作用，构建多元化的保障体系，支持商业保险机构发展保障范围涵盖新技术、新药品、新器械应用的商业健康保险产品。责任单位：市工信局、卫健委、医保局、财政局、三明银保监分局，各县（市、区）人民政府五、保障措施（一）加强组织领导。建立市政府分管领导担任召集人的三明市生物医药产业高质量发展工作联席会议制度，市工信局、发改委、科技局、财政局、人社局、生态环境局、农业农村局、林业局、商务局、卫健委、统计局、市场监管局、医保局、三明银保监分局、税务局、三明医学科技职业学院等市直有关部门单位为成员，统筹协调全市生物医药产业发展工作。联席会议下设综合协调组、项目推进组、技术攻关组、审批服务组、市场应用组和要素保障组，落细落实本行动计划明确的各项任务。责任单位：市生物医药产业高质量发展工作联席会议成员单位，各县（市、区）人民政府（二）加强资金支持。研究设立政府财政资金参与的市级生物医药产业引导基金,持续加大对生物医药产业重大科技攻关、产业化、创新平台、公共服务平台等支持力度，加强全产业链服务，积极申报和争取国家、省级各类资金支持和专项试点，激励高校院所、医疗机构、企业积极参与疫情防控应急医疗物资产业科研攻关、产业化，用好用足各项支持政策。各有关单位要细化政策实施细则，确保政策兑现落地、发挥资金效用。责任单位：市财政局、工信局、科技局、发改委、农业农村局、税务局，各县（市、区）人民政府（三）加大招商力度。依托我市资源优势，加大“以商招商”“产业链招商”力度，谋划对接一批优质招商项目落地。积极争取省药监局为我市开通二类医疗器械审评审批绿色通道，加快推动高质量医疗器械项目落地三明。建立项目“一对一”服务机制，加强要素保障，加快项目投产。对2022—2025年行动计划重点跟踪推进的21个项目，要坚持市县联动、专班推进，争取前期项目尽快落地转化、在建项目尽快竣工投产，并实行动态更新调整。责任单位：市工信局、发改委、商务局、财政局、生态环境局，各县（市、区）人民政府（四）加大人才支撑。对我市引进的医药企业管理和专业人才，符合条件的可享受市县相关人才扶持政策，同时按属地原则享受人才优惠政策，鼓励相关企业申报人才项目计划。鼓励本市高校和科研院所面向产业创新发展需求，精准实施人才培训计划，大力培养产业技术、市场营销、园区运营等各类专业人才，打造结构合理的生物医药产业人才梯队。支持上海中医药大学、上海健康医学院与三明医学科技职业学院建立对口帮扶机制，为三明定向培养医疗人才。责任单位：市委人才办，市人社局、财政局、工信局，各县（市、区）人民政府（五）加强政策宣传。加大惠企政策宣贯力度，充分运用好国家、省上和市级对生物医药产业的扶持政策，学习先进地区经验，不断完善细化相关支持举措。积极开展对规划目标、政策措施和重大项目等实施情况的跟踪分析，密切关注国内外生物医药产业发展动态，强化动态管理。建立年度分析评估机制，对本行动计划实施效果进行评估。责任单位：市直有关单位，各县（市、区）人民政府本行动计划执行期限为2022—2025年，具体解释工作由市工信局负责。原有政策与本行动计划规定不一致的，以本行动计划为准。本文件涉及省级财政资金奖补范围内的政策，由有关职能部门在省级财政资金中统筹安排；除明确规定由市级财政承担外，其他奖补资金按照“谁受益谁承担”原则，由受益地政府承担，从年初预算安排专项资金中列支，按“从优、不重复”的原则兑现。附件：三明市生物医药产业重点项目汇总表附件三明市生物医药产业重点项目汇总表序号项目名称建设内容及规模总投资（万元）项目建设年限建设(筹建、代建)单位项目属地责任单位合计（21项）一、前期项目（11项） 1 华润集团中医药产业园项目 1.共建中医药产业园。中关村科技园生物医药产业基地安排用地500亩以上，合作投资建设集中药制剂、中药配方颗粒、中药配送中心、中药材展示交易、中医药文化展览、药品供应链、人才信息交流为一体的特色中医药产业园。 2.共建中药材生产基地。依托三明丰富林下资源，发展一批可追溯、高品质中药材。结合沙县小吃富民特色产业，发展药食同源药膳包等特膳食品。 300000 2021-2025 华润集团有限公司清流县沙县区清流县政府/ 沙县区政府 2 年产1200吨医用造影剂系列产品建设项目总建筑面积79920平方米，建设年产1500吨医用造影剂系列产品生产线及配套设施。 68000 2022-2025 福建万科药业有限公司三元区三元区政府 3 含氟吡啶类医药中间体研发生产项目项目一期总建筑面积2.1万平方米，建设年产3000吨含氟吡啶类中间体；项目二期总建筑面积1.5万平方米，建设年产1800吨含氟杂环及相关中间体。 52000 2022-2025 三明明行健康科技有限公司三元区三元区政府 4 汇天生物1.1类中药创新药玉蝴蝶祛斑膏项目该项目为国医大师柴嵩岩的临床经验方，目前已完成临床II期试验，计划在2022年底出具临床总结报告并进行申报。本品一旦上市，将填补国内中药治疗黄褐斑医美领域的空白。 10000 2022-2025 福建汇天生物药业有限公司三元区三元区政府 5 海西联合药业吸入式麻醉剂及中间体技术改造和扩建项目项目规划总建筑面积1.2万平方米，计划建设年产1000吨七氟烷、900吨异氟烷、400吨地氟烷及吸入用七氟烷280万瓶、吸入用地氟烷100万瓶的生产线20条，同时引进意大利进口灌装线用于氟烷制剂生产。 20000 2022-2025 福建海西联合药业有限公司明溪县明溪县政府 6 药物综合性研发生产基地项目项目规划总建筑物面积8.2万平方米,分三期建设，计划依托母公司博悦生物的强大研发实力，从已开发项目中，选出具有自主知识产权的高技术壁垒原料药和制剂项目进行产业化生产，一期计划商业化生产磷酸盐结合剂、抗肿瘤等产品。 150000 2022-2025 上海博悦生物科技有限公司明溪县市工信局/明溪县政府 7 宁化医用同位素生产设施项目一期建设热功率20-30MW同位素生产堆一座，钼-99、碘-131、碘-125同位素生产车间，以及氘代医药中间体、BNCT专用硼同位素药等配套设施；二期工程规划开发以镥-177、锶-90、碳-14等为主要同位素产品的生产系统。 370000 2021-2025 福建清堆科技有限公司宁化县宁化县政府 8 沃兰香料项目项目占地68.5亩,年产系列香料3800吨，年产值可达3.5亿元，年创税1300万元以上。 31200 2020-2025 沃兰香料科技（福建）有限公司尤溪县尤溪县政府 9 欧劳福林项目项目占地71.2亩，采用国际先进技术建设生产车间，年产天然香料1000吨、合成香料3000吨、香精500吨，主要用于食用香精和日化香精的合成、植物精油生产。项目投产后，预计年产值6亿元，年创税2500万元以上。 39000 2020-2025 美国欧劳福林工业集团有限公司尤溪县尤溪县政府 10 医疗器械生产项目项目占地100亩，建设产品研发设计中心、高标准净化车间、产品包装线，办公及生活区域，相关配套设施等。主要从事于医疗器械、消毒用品、仪器仪表的研发、生产、销售。谋划项目 11 “药食同源”产品一体化生产项目项目占地100亩，建设中药饮片、中成药、中药材保健品加工车间、原料及成品仓库、综合办公楼，建设中药生产包装生产线。谋划项目二、在建项目（10项） 1 永安三氯蔗糖及营养补充物日化产品配料生产线建设项目总建筑面积5.4万平方米，一期新建年产1000吨三氯蔗糖生产线；二期新建年产1000吨三氯蔗糖、50吨褪黑素、1000吨氨基酸表面活性剂等生产线。 50000 2020-2023 福建科宏生物工程股份有限公司永安市永安市政府 2 永安劲美生物年产5万吨植物精油深加工项目总建筑面积6万平方米，建设厂房、仓库、办公楼等配套设施，新建年产5万吨植物精油深加工生产线。 50000 2020-2023 永安劲美生物科技有限公司永安市永安市政府 3 永安华药生物年产1万吨医药中间体项目总建筑面积5万平方米，建设10幢仓库、1幢综合楼、1幢研发楼等，新建年产1万吨医药中间体原料药生产线。 36000 2019-2022 福建华药生物技术有限公司永安市永安市政府 4 永安顺发生物愈创木酚系列产品生产项目建设年产2280吨天然4-甲基愈创木酚、4-乙基愈创木酚、愈创木酚系列产品、年产30吨西瓜酮、年产200吨天然香兰素的生产线。 10600 2021-2023 永安顺发生物科技有限公司永安市永安市政府 5 明溪沃林大健康系列产品生产项目总建筑面积3.8万平方米，建设综合业务楼、中药饮片生产车间、SC产品和特医食品生产车间、中药配方颗粒生产车间，产品质量检测中心，配套建设园区道路、绿化附属设施，建成SC产品、中药饮片、中药配方颗粒生产线各2条。 32000 2021-2025 明溪沃林生物技术开发有限公司明溪县明溪县政府 6 熙翔制药原料药和高端中间体研发生产项目一期总建筑面积3万平方米，新建合成车间、精烘包车间、GMP仓库、质检中心及配套水电、污水处理、罐区等附属设施，建成年产原料药10吨及高端中间体50吨生产线。 30000 2022-2024 福建熙翔制药有限公司明溪县明溪县政府 7 明溪南方制药抗肿瘤新药系列产品生产项目（三期）总建筑面积3万平方米，建设植物综合提取中心、质量检测及认证中心、企业技术研发及中试中心、智能化绿色高端定制原料药生产车间9个，建设年产4000吨植物提取物和2000吨化学合成原料药生产线。 15000 2022-2023 福建南方制药有限公司明溪县明溪县政府 8 沙县楚兴医药中间体生产项目总建筑面积3.52万平方米，建设年产1千吨嘧菌酯中间体生产线和年产1500千克抗心衰药物沙库比曲药物及前体建设生产线。 20000 2020-2022 福建楚兴药业有限公司沙县区沙县区政府 9 清流高纯级氟化锂及医药化学品生产项目总建筑面积2.69万平方米，建设年产1000吨高纯氟化锂、5000吨2.6-二氯苯酚、200吨间苯三酚，副产2000吨氯化钾、副产4200吨31%盐酸。 31000 2022-2024 三明博思韬科技有限公司清流县清流县政府 10 将乐县维生素D3生产项目总建筑面积3.3万平方米，新建生产车间，生产仓库，污水处理池，雨水收集池及其附属设施，建成维生素D3生产线7条，年产1000吨维生素D3。 20000 2022-2025 福建东汇生物医药有限公司将乐县将乐县政府

Ask the evidence.

三明市人民政府关于印发三明市加快生物医药产业高质量发展行动计划（2022—2025年）的通知

Country-interest evidence · pilot

Measures

Same central policy, other provinces

Full text